Vitamin B3 therapy offers hope for fatal childhood disease
Medical Xpress
February 25, 2026
AI-Generated Deep Dive Summary
Scientists at Gladstone Institutes have made a groundbreaking discovery by reversing the traditional approach to finding treatments for deadly diseases. Instead of starting with a disease and searching for a cure, they began with vitamins—specifically Vitamin B3—and systematically identified genetic diseases that could benefit from high-dose supplements. This innovative method has yielded promising results in treating fatal childhood diseases.
The research focused on a rare and potentially fatal genetic disorder known as Donavant's disease. By administering high doses of Vitamin B3, also called niacin, the scientists were able to correct the metabolic defects caused by the disease. This approach not only provided immediate benefits but also opened up new possibilities for treating other genetic disorders through vitamin therapy.
The significance of this breakthrough lies in its potential to transform how we approach rare and deadly diseases. By leveraging vitamins as a tool, researchers can identify diseases that respond effectively to specific nutritional interventions. This shift from disease-centered to nutrient-driven research could pave the way for more personalized and effective treatments.
For patients and families affected by fatal childhood diseases, this news offers hope. The ability to use simple, readily available supplements like Vitamin B3 to combat severe genetic disorders marks a significant step forward in medical science. It also highlights the importance of exploring alternative treatment methods beyond traditional drugs and therapies.
This research not only advances our understanding of genetic diseases but also underscores the potential of vitamins and nutrients as powerful tools in precision medicine. As scientists continue to explore this approach, it could lead to new treatments for a wide range of conditions, bringing hope to patients worldwide.
Verticals
healthmedical
Originally published on Medical Xpress on 2/25/2026